Failure of Responsive Regulation?: Pharmaceutical Marketing, Corporate Impression Management and Off-Label Promotion of Enzalutamide in Europe

Shai Mulinari; Courtney Davis; Piotr Ozieranski

Failure of Responsive Regulation? Pharmaceutical Marketing, Corporate Impression Management and Off-Label Promotion of Enzalutamide in Europe

Shai Mulinari^*, Courtney Davis, Piotr Ozieranski

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	69-80
Number of pages	12
Journal	Journal of White Collar and Corporate Crime
Volume	2
Issue number	2
Publication status	Published - 2021

Access to Document

https://doi.org/10.1177/2631309X20970477

Cite this

@article{19f22a46901a4c7ab05f6bf2d71654e0,

title = "Failure of Responsive Regulation?: Pharmaceutical Marketing, Corporate Impression Management and Off-Label Promotion of Enzalutamide in Europe",

author = "Shai Mulinari and Courtney Davis and Piotr Ozieranski",

year = "2021",

language = "English",

volume = "2",

pages = "69--80",

journal = "Journal of White Collar and Corporate Crime",

issn = "2631-309X",

publisher = "Sage Publishing",

number = "2",

}

TY - JOUR

T1 - Failure of Responsive Regulation?

T2 - Pharmaceutical Marketing, Corporate Impression Management and Off-Label Promotion of Enzalutamide in Europe

AU - Mulinari, Shai

AU - Davis, Courtney

AU - Ozieranski, Piotr

PY - 2021

Y1 - 2021

M3 - Article

SN - 2631-309X

VL - 2

SP - 69

EP - 80

JO - Journal of White Collar and Corporate Crime

JF - Journal of White Collar and Corporate Crime

IS - 2

ER -